Vanguard Group Portfolio holdings
AUM
$6.18T
1-Year Return
25.19%
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
This Quarter Return
+4.7%
1 Year Return
+25.19%
3 Year Return
+103.99%
5 Year Return
+190.29%
10 Year Return
+458.75%
AUM
$2.39T
AUM Growth
+$104B
(+4.5%)
Cap. Flow
+$27.7B
Cap. Flow
% of AUM
1.16%
Top 10 Holdings %
Top 10 Hldgs %
14.86%
Holding
4,206
New
109
Increased
2,937
Reduced
921
Closed
76
Top Buys
| 1 |
AT&T
T
|
$2.65B |
| 2 |
American Tower
AMT
|
$1.84B |
| 3 |
Evergy
EVRG
|
$1.65B |
| 4 |
Alibaba
BABA
|
$1.5B |
| 5 |
Crown Castle
CCI
|
$1.26B |
Top Sells
| 1 |
TWX
Time Warner Inc
TWX
|
$4.88B |
| 2 |
MON
Monsanto Co
MON
|
$3.71B |
| 3 |
Microsoft
MSFT
|
$1.68B |
| 4 |
CSRA
CSRA Inc.
CSRA
|
$697M |
| 5 |
WR
Westar Energy Inc
WR
|
$688M |
Sector Composition
| 1 | Technology | 16.62% |
| 2 | Financials | 15.45% |
| 3 | Healthcare | 12.41% |
| 4 | Consumer Discretionary | 10.23% |
| 5 | Industrials | 10.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3401
BioXcel Therapeutics
BTAI
$55.2M
| $2.77M | ﹤0.01% |
18,800
+362
| +2% | +$53.3K |
|
|
CFMS
3402
DELISTED
Conformis, Inc. Common Stock
CFMS
| $2.75M | ﹤0.01% |
88,068
+5,488
| +7% | +$171K |
|
|
EEQ
3403
DELISTED
Enbridge Energy Management Llc
EEQ
| $2.74M | ﹤0.01% |
275,953
+10,884
| +4% | +$108K |
|
|
SQBG
3404
DELISTED
Sequential Brands Group, Inc.
SQBG
| $2.72M | ﹤0.01% |
34,559
-2,398
| -6% | -$189K |
|
3405
Kamada
KMDA
$411M
| $2.72M | ﹤0.01% |
522,931
+7,213
| +1% | +$37.5K |
|
|
NOVN
3406
DELISTED
Novan, Inc. Common Stock
NOVN
| $2.72M | ﹤0.01% |
92,361
+25,702
| +39% | +$756K |
|
|
MACK
3407
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $2.71M | ﹤0.01% |
702,675
-57,904
| -8% | -$224K |
|
|
BCLI
3408
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $2.71M | ﹤0.01% |
46,282
+947
| +2% | +$55.4K |
|
3409
Natural Alternatives International
NAII
$22.2M
| $2.71M | ﹤0.01% |
266,475
+339
| +0.1% | +$3.44K |
|
3410
Celsius Holdings
CELH
$15B
| $2.7M | ﹤0.01% |
1,757,895
+429,534
| +32% | +$659K |
|
|
ONCS
3411
DELISTED
OncoSec Medical Incorporated
ONCS
| $2.69M | ﹤0.01% |
8,871
+154
| +2% | +$46.8K |
|
3412
Inseego
INSG
$199M
| $2.67M | ﹤0.01% |
132,662
+541
| +0.4% | +$10.9K |
|
3413
IRIDEX
IRIX
$23.8M
| $2.66M | ﹤0.01% |
392,547
-3,635
| -0.9% | -$24.7K |
|
|
VIVE
3414
DELISTED
VIVEVE MED INC
VIVE
| $2.65M | ﹤0.01% |
974
-19
| -2% | -$51.7K |
|
|
BCRH
3415
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
| $2.65M | ﹤0.01% |
239,760
-661
| -0.3% | -$7.3K |
|
3416
Genasys
GNSS
$89.4M
| $2.61M | ﹤0.01% |
993,539
+63
| +0% | +$166 |
|
3417
Aware
AWRE
$48.4M
| $2.6M | ﹤0.01% |
642,621
+13,237
| +2% | +$53.6K |
|
3418
Kiniksa Pharmaceuticals
KNSA
$2.65B
| $2.6M | ﹤0.01% |
+150,000
| New | +$2.6M |
|
|
EDGW
3419
DELISTED
Edgewater Technology Inc
EDGW
| $2.58M | ﹤0.01% |
475,686
+16,617
| +4% | +$90.1K |
|
|
ADXS
3420
DELISTED
Advaxis, Inc.
ADXS
| $2.57M | ﹤0.01% |
118,242
-21,776
| -16% | -$474K |
|
3421
Adicet Bio
ACET
$60M
| $2.57M | ﹤0.01% |
40,135
+6,291
| +19% | +$403K |
|
3422
Brown-Forman Class A
BF.A
$13.8B
| $2.54M | ﹤0.01% |
51,947
+4,137
| +9% | +$202K |
|
3423
Citizens Community Bancorp
CZWI
$163M
| $2.54M | ﹤0.01% |
179,250
+4,464
| +3% | +$63.2K |
|
|
HUD
3424
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $2.52M | ﹤0.01% |
144,165
+35,465
| +33% | +$620K |
|
|
IMBI
3425
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
| $2.52M | ﹤0.01% |
204,981
+9,587
| +5% | +$118K |
|